RxDoctor Payments Data

Dawn Wolak

Adult Health · Smyrna, GANPI 1093815235

Payments from drug & device makers

$4,494in general payments, 2019–2025

Across 215 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$851
  • Xeris Pharmaceuticals, Inc.$515
  • Sanofi-aventis U.S. LLC$380
  • Novo Nordisk$282
  • Amgen$273
  • Cequr Corporation$266
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$4,494100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,494 in reported general payments places this provider in the 85th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide151$189,600
OzempicSemaglutide79$91,932
JardianceEmpagliflozin59$66,217
TrulicityDulaglutide40$46,466
FarxigaDapagliflozin Propanediol33$34,242
InvokanaCanagliflozin19$18,756
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog34$18,490
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$16,356
Tresiba Flextouch U-100Insulin Degludec18$16,241
Synjardy XrEmpagliflozin/Metformin Hcl12$9,706
JanuviaSitagliptin Phosphate16$9,085
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$7,455
Liothyronine Sodium134$5,865
HumalogInsulin Lispro16$5,714
Humalog Kwikpen U-100Insulin Lispro31$5,561

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$851$241,780207 claims
Novo NordiskOzempic$282$91,93279 claims
Boehringer IngelheimJardiance, Synjardy Xr$138$75,92371 claims
AstraZenecaFarxiga$217$34,24233 claims
MerckJanuvia$15$9,08516 claims
AbbVieSynthroid, Armour Thyroid$59$5,31679 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$35$2,337234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 577 adult health providers in Georgia.

Other adult health in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →